The Role of Genetic Variants on Psychedelics' Therapeutic Effects

Genetic variants of the 5-HT2A serotonin receptor may explain why some respond to psychedelic therapies for the treatment of mental health disorders while others don't.

Related Keywords

,Samuel Slocum ,Manish Jain ,Gavin Schmitz ,Bryan Roth ,Mark Derewicz ,School Of Medicine ,Psychotropic Drug Screening Program ,Defense Advanced Research Projects Agency ,National Institutes Of Health ,Michael Hooker Distinguished Professor ,Drug Screening ,National Institutes ,Pharmacological Signaling ,Potentially Therapeutic ,Neuroscience Newsletter ,